The Technical Network for Strengthening Immunization Services
We are a global network of immunization professionals committed to strengthening immunization services by building relationships, sharing knowledge, coordinating activities, and aligning priorities and goals. Learn More.
Looking for an immunization resource?
Our Knowledge Hub, built and curated by TechNet members, contains thousands of key immunization resources from around the world.
The Access to COVID-19 Tools (ACT) Accelerator’s Country Readiness and Delivery (CRD) workstream, Project ECHO, Boost, TechNet-21, and the COVID-19 Vaccine Equity Project invite you to join a series of video-conference-based capacity building webinars.
Topic: Regulatory and Procurement Aspects for COVID-19 Vaccines
When: 9 March session (12-1PM CET)
Registration: https://echo.zoom.us/webinar/register/WN_60QBnRtURmaoXz2mGFWPIQ
TechNet-21 also manages two Telegram channels supporting regions, countries, and partners in preparing for COVID-19 vaccine introduction. In these two spaces - one anglophone and one francophone - you will be able to share your experiences, discuss key questions, and connect with experts from around the world. We'll also share new information and global guidance as it becomes available. Join us today:
COVID-19 Vaccine Introduction – TechNet-21 (English)
Introduction des vaccins contre la Covid-19 – TechNet-21 (Français)
Dear colleagues,
The recording of the webinar on Regulatory and Procurement Aspects for COVID-19 Vaccines is available in three languages here:
https://youtu.be/fY3vGBo9CQ0 (English)
https://youtu.be/0rGU1cSToX4 (Spanish)
https://youtu.be/TFHdx4j_fI8 (French)
Dear colleagues,
The questions that could not be answered during the webinar session have been compiled into the following Q&A document:
These are the questions that have been answered:
- Is there a link for the COVAX tracker?
- In Latin America, which countries have sent requests to the manufacturers for the test, because in PERU, it takes time, and it is not done yet.
- By not allowing or supporting testing by NRAs not creating a perception issue? If so, how is communication done to allay the anxiety in countries that may not be comfortable on this?
- Some NRAs have granted emergency use of the COVID-19 vaccines but continue to take samples of the vaccine in-country for testing. Are we saying NRAs shouldn't test all?
- Any list of the 48 PIP countries available?
- Are vaccines being approved for safety and quality by the manufacturing site (as is usual with usual medicines following Good Manufacturing Practice etc), or is the approval for emergency use and listing just by product? The concern is from partners at country level that different manufacturing sites (for the same product) will have different quality assurance mechanisms, and indeed for FCV countries may receive those which are sub-standard/ of poorer quality.
You can now find all the resources for all the COVID-19 Vaccine Introduction webinar sessions here: https://www.technet-21.org/en/topics/covid-19-vaccine
- Page :
- 1
Our community, our knowledge
6153 members
TechNet members are immunization professionals working to improve immunization services in every country and at all levels from global policy formulation and national programme management all the way to service delivery at subnational levels.
- Connect with each other and make new contacts
- Ask questions, provide answers, and share knowledge in our forum
- Join specialist groups (communities of practice)
- Track upcoming events, such as webinars, training opportunities and global events
- Browse key publications on Hot Topics curated by global experts
- Search for guidance in our Knowledge Hub
Our Partners
We are proud to work with many organizations and initiatives across the world in our efforts to help strengthen immunization services. We support the work of all immunization professionals, from both the public and private sector, from governments and international organizations to NGOs, academic institutions, companies and manufacturers. TechNet is a member of two global immunization partnerships:
Gavi Alliance’s immunization Supply Chain Steering Committee (iSC2)
Partnership of Immunization Networks
